Application notes

Neuroscience

• 213_018_03 - Dual cell control for improved selectivity
• 213_019_08 - GABA and Glutamate DCC
• 213_020_02 - Fast analysis of GABA and Glutamate
• 213_022_06 - Acetylcholine and Choline
• 213_023_01 - Acetylcholine
• 213_025_03 - Monoamines analysis in microdialysates
• 213_026_01 - Compilation of Neuroscience Applications
• 213_027_02 - ALEXYS Neurotransmitter Analyzer
• 220_001_04 - Attomole detection limits
• 220_005_04 - Reference electrode recommendations
• 220_011_05 - Micro volume injections

Pharmaceutical & Biotech

• 211_004_04 - Glutathione and Other Disulfides
• 217_010_10 - Neomycin and Framycetin sulfate in bulk drug
• 217_013_09 - Gentamicin Sulphate in Pharmaceutical Preparations
• 217_014_06 - Tobramycin in Pharmaceutical Preparations
• 217_015_06 - Amikacin and Kanamycin in Bulk Drugs
• 217_017_07 - Azithromycin, Erythromycin and other Macrolide Antibiotics
• 217_018_07 - Spectinomycin in Pharmaceutical Preparations
• 217_019_05 - Spectinomycin and Lincomycin
• 217_023_04 - Fluorodeoxyglucose.
• 217_025_02 - Compilation of Pharmaceutical Application

Food / Beverage & Environmental

• 212_004_02 - Iodide in Milk
• 216_003_01 - Phenols in Water
• 216_005_04 - Bisphenol A in Water
• 216_006_03 - Polyphenols in Wine and Food
• 220_002_04 - Carbohydrates in Food

Clinical & Diagnostics

• 214_001_03 - Catecholamines in Urine
• 214_002_03 - Catecholamines in Plasma
• 214_003_03 - Serotonin in Urine
• 214_004_03 - Serotonin in Plasma
• 214_005_03 - Metanephrines in Urine
• 214_006_03 - HVA, VMA and 5HIAA in Urine
• 214_007_02 - Compilation of Clinical Applications

Electrochemistry / MS

• 210_001A_04 - ROXY Event programming and Settings
• 210_001_07 - Oxidative Metabolism of Acetaminophen
• 210_002A_01 - ROXY ECLC system userdefined programs for AS 110
• 210_002_01 - Automated screening with ROXY ECLC system
• 210_003_01 - uPrepCell for Metabolite Synthesis
• 210_004_04 - Oxidative Metabolism of Amodiaquine